BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 19021025)

  • 21. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experiences with nimodipine in cerebral ischemia.
    Kakarieka A; Schakel EH; Fritze J
    J Neural Transm Suppl; 1994; 43():13-21. PubMed ID: 7884395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective pharmacologic treatments for subarachnoid hemorrhage].
    Carteri A; Billeci D; Copetti E
    Minerva Anestesiol; 1998 May; 64(5):257-9. PubMed ID: 9773673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Dalal PM; Dalal KP
    J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nimodipine reduces morbidity, mortality after disruption of cerebral blood flow.
    Carmody J; Lilly JK
    W V Med J; 1990 Feb; 86(2):49-51. PubMed ID: 2408232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemorheological disturbances and possibility of their correction in cerebrovascular diseases.
    Forconi S; Turchetti V; Cappelli R; Guerrini M; Bicchi M
    J Mal Vasc; 1999 May; 24(2):110-6. PubMed ID: 10399643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G; Carley S
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders.
    Sabbatini M; Strocchi P; Amenta F
    Clin Exp Hypertens; 1995 Jul; 17(5):719-50. PubMed ID: 7655445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemia triggered by red blood cell products in the subarachnoid space is inhibited by nimodipine administration or moderate volume expansion/hemodilution in rats.
    Dreier JP; Windmüller O; Petzold G; Lindauer U; Einhäupl KM; Dirnagl U
    Neurosurgery; 2002 Dec; 51(6):1457-65; discussion 1465-7. PubMed ID: 12445352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nimodipine: test your drug IQ.
    Devlin MM
    Nursing; 2008 Jul; 38(7):56cc1-2. PubMed ID: 18580671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
    Sakowitz OW; Unterberg AW
    Curr Opin Crit Care; 2006 Apr; 12(2):103-11. PubMed ID: 16543784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage.
    Ma B; Zhang J
    Brain Res; 2006 Mar; 1078(1):182-8. PubMed ID: 16492378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure augmentation in acute ischemic stroke.
    Wityk RJ
    J Neurol Sci; 2007 Oct; 261(1-2):63-73. PubMed ID: 17582440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenge of blood pressure management in neurologic emergencies.
    Talbert RL
    Pharmacotherapy; 2006 Aug; 26(8 Pt 2):123S-130S. PubMed ID: 16863478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiorespiratory problems in the use of calcium antagonists for vasospasm prophylaxis in subarachnoid hemorrhage].
    Guggenberger H; Kottler B; Heuser D
    Anaesthesist; 1986 Jul; 35(7):429-32. PubMed ID: 3752488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nicardipine and its indications in neurology].
    Moltó-Jordà JM; Matías-Guiu J
    Rev Neurol; 1997 Aug; 25(144):1235-41. PubMed ID: 9340158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.